FDA Approves Polarizing First Drug for Duchenne Muscular Dystrophy

On Monday morning, the FDA controversially approved the first drug for Duchenne muscular dystrophy. Read more on how the drug works and what impact this will have in healthcare and medicine!

Advertisements

Last Week in Science (9/4-9/10)

First Alzheimer’s treatment, sickle-cell gene therapy and more!

Update on CRISPR: Closer to human trials?

Remember when we talked about CRISPR a little over a month ago? And we dreamt of the positive impact it could have on humans in the future? Well, dream no more–that day may be much sooner than we expected.

CRISPR: The Future of Science is Here

CRISPR, the latest genome-editing technology, has been making the headlines in almost every major science journal, heralding a “new era” for science. Why is CRISPR such a big deal? Better yet, what is CRISPR?

Are Superheroes Among Us?

As we all remember from 8th grade biology, Gregor Mendel is known as the “father of modern genetics.” Mendel’s experiments with pea plants made him realize that there are certain genetic traits (he was testing pea size, shape, color, etc.) that get passed down to the offspring. This inheritance of genetic traits is based on…

The Evolution of Medicine and Where We’re Headed in the Future

Hippocrates, the “Father of Western Medicine,” is arguably one of the most iconic physicians in history. Born in 460 BC, his influence has been long-lasting and far-reaching; in fact, medical students today recite the “Hippocratic Oath” to ensure that as future physicians, they understand the significance and seriousness of taking on the role of being…

New Study Helps Decode Inherited Heart Disease

Two weeks ago President Barack Obama gave his State of the Union Address where he unveiled his Precision Medicine Initiative, which relies on genomics to “deliver the right treatment at the right time.” While NAG’s focus has been to deliver genomic medicine to physicians and patients around the country, we delight in the growing support…

Genomics Only Revolutionary With Broad Access

There are many barriers currently in place preventing patients from getting their DNA sequenced, especially among minorities. Many facilities offer limited testing in the form of gene panels, but they are expensive, and often require patients to pay out of pocket. While out of pocket spending rises with income, the strain of this type of…

Confidence in Variants? Release the Data!

  Next generation sequencing tests are widely being adopted in oncology and many patients are benefiting. However, when assessing hereditary risk for cancer, sometimes results may come back that are difficult to fully understand. Reports may detail a “Variant of Unknown Significance”, also known as a VUS, which means that a mutation was found that has…

FH Awareness Day

Today is Familial hypercholesterolemia, or FH, awareness day. FH is a hereditary disease that leads to early and aggressive heart-issues for the sufferer. Nearly 1 in 200-500 people in the United States have FH, but it is suspected that only 10% of cases are diagnosed. Currently, family history of early cardiac events and high-cholesterol are…

Is Cancer Overdiagnosed?

There is a growing debate in healthcare, spurred by an advisory panel for National Cancer Institute, that says cancer is being over-diagnosed. There is no doubt that early-detection of cancer has saved lives, especially for the more aggressive varieties. The argument goes that early-detection screenings have become more widespread, but doctors still aren’t catching a…